Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
Public ClinicalTrials.gov record NCT00654706. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomised, Double-Blind, Parallel-Group, Flexible-Dose Study Exploring the Neurocognitive Effect of Sertindole Versus Comparator in Patients With Schizophrenia Using the MATRICS Consensus Cognitive Battery (MCCB)
Study identification
- NCT ID
- NCT00654706
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- H. Lundbeck A/S
- Industry
- Enrollment
- 264 participants
Conditions and interventions
Conditions
Interventions
- Quetiapine Drug
- Sertindole Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2008
- Primary completion
- Dec 31, 2009
- Completion
- Feb 28, 2010
- Last update posted
- May 27, 2014
2008 – 2010
United States locations
- U.S. sites
- 26
- U.S. states
- 12
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| US017 | Garden Grove | California | 92845 | — |
| US008 | National City | California | 91950 | — |
| US001 | Pasadena | California | 91107 | — |
| US006 | Pico Rivera | California | 90660 | — |
| US011 | San Diego | California | 92126 | — |
| US014 | Stanford | California | 94305 | — |
| US026 | Torrance | California | 90502 | — |
| US016 | Aurora | Colorado | 80045 | — |
| US015 | Orange City | Florida | 32763 | — |
| US010 | Tampa | Florida | 33613 | — |
| US007 | Atlanta | Georgia | 30308 | — |
| US024 | Chicago | Illinois | 60640 | — |
| US002 | Joliet | Illinois | 60435 | — |
| US012 | Baltimore | Maryland | 21204 | — |
| US027 | Glen Burnie | Maryland | 21061 | — |
| US019 | Lebanon | New Hampshire | 03756 | — |
| US021 | Clementon | New Jersey | 08021 | — |
| US013 | Brooklyn | New York | 11203 | — |
| US025 | Staten Island | New York | 10305 | — |
| US005 | Charlotte | North Carolina | 28211 | — |
| US018 | Durham | North Carolina | 27705 | — |
| US022 | Philadelphia | Pennsylvania | 19139 | — |
| US023 | Austin | Texas | 78754 | — |
| US020 | Dallas | Texas | 75235 | — |
| US004 | DeSoto | Texas | 75115 | — |
| US028 | Houston | Texas | 77008 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00654706, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 27, 2014 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00654706 live on ClinicalTrials.gov.